We’ve been talking about this a lot lately: BIOTECH IS ON FIRE! If you look at the biotech ETF – IBB – it has booked new highs almost every day for the last TWO WEEKS and many sector stocks have followed suit! It so happens that this morning we’ve got big, breaking news & top stories coming from this red hot market. Check out today’s premarket newsletter, now:
GT Biopharma (GTBP) Announces Solid Tumor Targeting TriKe™ Kills Non-small Cell Lung Cancer (NSCLC) Tumor Cells
This morning GT Biopharma, Inc. (GTBP) announced that Drs. Jeffrey Miller, Martin Felices and Pippa Kennedy from the University of Minnesota presented research results at the recently concluded 18th meeting of the Society for Natural Immunity concerning a solid tumor targeting TriKE™ which demonstrates killing of non-small cell lung cancer tumor cells!
See For Yourself
Are These Biotech Names On Your October Watch List?
Over the past two decades, the biotech sector has been one of the best sectors to watch. If experts are to be believed, then it is likely to continue to be a hot sector for the foreseeable future. However, biotech stocks require research and that can help when it comes to making a list of stocks to watch this month.
Click To Read More
A Growing Need For Security Solutions Puts Sector Stocks On Watch
With recent growing concerns in countries abroad, many people around the world are beginning to feel uneasy. From degenerating relationships between the US and China or recent events in the Middle East, one thing is for sure, the world is as dangerous as ever.
Continue Reading
Pursuant to an agreement between Midam Ventures LLC and GT Biopharma (GTBP), Midam has been paid $100,000 for a period from October 1, 2019 to November 15, 2019. We may buy or sell additional shares of GT Biopharma (GTBP) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about GT Biopharma (GTBP). Click Here For Full Disclaimer.
